
Harvinder Virk
@harvin_der_virk
I use LinkedIn and do not monitor this account frequently
ID: 1178349211559047169
https://orcid.org/0000-0002-9739-9593 29-09-2019 16:42:09
273 Tweet
156 Followers
285 Following


Thank you to Rick Kahn, eLife - the journal and all of the co-authors for this excellent overview of initiatives that have and are improving science using antibodies. Keep up the good work everyone! doi.org/10.7554/eLife.…


📢📢 📢 all healthcare professionals #breathlessness 👋 🌟 last few days to complete Asthma + Lung UK JLA PSP survey to set top 10 research priorities for #breathlessness 🌟 particularly need more #GPs and #respisbest cons 🌟 pls complete by 31st Aug 👇 bit.ly/3NWJvne


Thanks Research at Leicester's Hospitals Very pleased 😊


Dr Katy Roach Fasi Khan Gauri Saini Chris Huntley Louise Crowley Dr Rahul Mahida Dhruv Parekh Aaron Scott Harvinder Virk OnlyGoodAntibodies YCharOS Consistently great questions from Action for Pulmonary Fibrosis’s Clare Hodkinson, bridging the science and patient perspectives.

Harvinder Virk #EMIRA speaking to the challenges of progressing drug development & research alongside MDT assessment delays... strategies afoot including YCHARUS better antibodies better science better patient outcomes Amanda Tatler Bibek Gooptu ILD-IN




Thrilled to see our own Carl Laflamme and Riham Ayoubi featured in this Nature article for their fantastic antibody characterization work!

Thank you Diana Kwon for the great news feature in Nature about the public good YCharOS effort






✍️🚨Check out this *new #blog* from the #NIHRLeicesterBRC's Harvinder Virk “New protocol will drive a shared roadmap towards more reliable and cost-effective use of #antibodies in biomedical research.” including links to papers published in Nature Protocols this month.
